Tendinitis Treatment Market Share

Global Tendinitis Treatment Market Overview

The Tendinitis treatment market is anticipated to reach USD 263.95 Billion by 2032 at 3.7% CAGR during the forecast period 2023-2032.

The growth of the aging population is leading to rising in the number of tendinitides. The increased rate of sports and occupational injuries is leading to the market’s growth in the forecast period. The higher usage of electronic devices is further leading to hands, and wrist-related problems, which develop the chances of tendonitis. The occurrence of sudden injuries, side effects of treatment, and prolonged inactivity of the body stiff joints are factors restraining market growth.

In November 2022, Camber Pharmaceuticals included Naproxen Oral Suspension to its product portfolio as an addition for treating tendonitis symptoms.

CoNextions Inc., a tendon repair manufacturer, said on May 2022 that the first patient had been treated nineteen days after receiving FDA 510(k) approval to market the device with the CoNextions TR Tendon Repair System towards a zone 2 flexor tendon of the little finger.

Boehringer Ingelheim announced in April 2022 that RenuTrend was being launched as a better stem cell therapy for enhancing healing of tendons and suspensory ligament injuries. In Europe, RenuTrend has received approval as the first licensed product which is given by intralesional injection and will be complementing their other equine stem cell products.

In Dec. 2021, Delsson partnered with experts from Nanyang Technological University (NTU) engaged in 3D printing to come up with X-Brace, which is nearly 30% lighter than conventional exoskeleton knee braces.

The Citrelock Tendon Fixation Device System was unveiled by Stryker in September 2021 without injuring the tendon during replacement surgery. It includes “Citregen,” a resorbable material for tendon thread made of citrate, calcium & phosphate elements essential for bone formation.

As an example, Ossur, an international leader in prosthetic and non-invasive orthopedic technologies, released its new Rebound Post-Op Elbow Brace on September 2021, which is designed to offer elbow immobilization and range-of-motion restrictions for various conditions like chronic elbow injuries or tennis elbow release; it is also lightweight and adjustable as well as non-invasive.

In July 2021, InGeneron released adult soft tissue repairs facilitated through local fresh undeveloped unmodified autologous adipose-derived regenerative cells—the first in human comprehensive immunohistochemical characterization.

The global medical technology company, Smith+Nephew (LSE:SN, NYSE:SNN), has today announced the launch of its REGENETEN Bioinductive Implant in India. This announcement was made in July 2023. The REGENETEN implant has revolutionized the way surgeons approach rotator cuff procedures, with over 100,000 procedures completed globally since its introduction. The REGENETEN Bioinductive Implant, which is composed of collagen, facilitates the body's natural healing response by promoting the development of new tendon-like tissue. This tissue serves to biologically augment the existing tendon and alter the progression of the disease. 

The implant is approximately the size of a postage stamp and is delivered arthroscopically through a small incision over the location of the rotator cuff tendon injury. By six months, the implant is no longer visible, and new tendon-like tissue and oriented collagen suggestive of functional loading have developed. With more than a decade of clinically demonstrated results in 18 studies that encompass the entire continuum of rotator cuff disease, from partial thickness tears to large (3-5cm) and massive (5cm+) full-thickness tears, the REGENETEN Bioinductive Implant is now available in India. The most recent data from a triple-blinded randomized controlled trial has demonstrated that the REGENETEN Bioinductive Implant, when incorporated into a conventional rotator cuff repair, results in a relative reduction of 86% in re-tear rates at 12 months when compared to conventional surgery alone.

The sports-related injuries are highly propelling the market. The rapid growth of sports activities leads to soft tissue injuries, a major driver of the market. The encouraging career opportunities and inclination toward fitness let people form their careers in the sports field. This factor increases the chances of incurring injuries that are driving the Tendinitis Treatment Market.

The clinical grafts in tendon treatment and significant demand for alternative engineered tissue are setting wide opportunities for the market. The growing need for innovative strategies for tendon replacement and regeneration will help the market reach its estimated growth rate.

Study objectives of Tendinitis treatment market:

• To provide detailed analysis of the tendinitis treatment market structure with historical and forecast revenue for the next six years of the various segments and sub-segments.


• To provide insights about the key drivers, restraints, opportunities and challenges affecting the growth of tendinitis treatment market


• To provide analysis of the market with respect to various countries in the four main geographies– the Americas, Europe, Asia Pacific, and Middle East & Africa.


• To provide detailed analysis of the market segmented by condition, diagnosis, treatment, end user, and its sub-segments.


• To provide a detailed analysis of tendinitis treatment market mainly based on Value Chain Analysis, Porter’s Five Forces, Price Analysis, and Supply Chain Analysis etc.


• To provide a detailed country level analysis of the market with respect to the current market size and future prospects


• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the tendinitis treatment market


• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the tendinitis treatment market

Key players for Tendinitis treatment market:Some of the key players in this market are: Almatica Pharma, Inc. (US), AstraZeneca (US), Bayer (Germany), Boehringer Ingelheim Pharmaceuticals, Inc. (US), Merck & Co., Inc (US), Pfizer (US), and others.

Segments:

Tendinitis treatment market has been segmented on the basis of condition which comprises of tennis elbow, golfer's elbow, pitcher's shoulder, swimmer's shoulder, jumper's knee, and others.

On the basis of diagnosis, the market is segmented into physical exam, imaging tests, and others. Imaging test is sub-segmented into ultrasound, Magnetic Resonance Imaging (MRI) scans, and others.

On the basis of treatments, the market has been segmented into medications, therapy, surgical repair, and others. Medication sub-segmented into pain relievers, corticosteroids, Platelet-Rich Plasma (PRP), and others. Therapy is further sub-segmented into hot and cold therapy, physical therapy, occupational therapy, and others.

On the basis of end user, it is segmented into hospitals & clinics, medical research centers, academic institutes, and others.

Regional analysis of Tendinitis treatment market:

Considering the global scenario of the market, America is the top contributor in this market. The Americas mainly includes North America and South America. Due to developed healthcare infrastructure and increasing R&D funding, US is dominating country in this region. Europe is second largest market for tendinitis treatment. Due to innovative product development and rapid adoption of new treatments, Germany is dominating this market. Asia Pacific is witnessing rapid growth in this market which is mainly due to rapidly changing healthcare sector, increasing awareness, and rising healthcare expenditure. Middle East and Africa is expected to have limited growth while Middle Eastern countries are expected to dominate this market during the forecast period.

Recent Development

In April 2022

The addition of Dr. Coombs to our team, Affectionately Cats in Williston will offer acupuncture for the feline friends. There benefits to acupuncture for cats. It is used to treat chronic and acute pain syndromes as well as osteoarthritis, tendonitis, spinal injury, disk disease, and more. It directly releases tension and stimulates endorphin release providing relaxation to the patient while increasing blood flow and regeneration of tissue in damaged areas.

Medical acupuncture is a method that usually involves the sterile needles. Modern medical practitioners developed acupuncture as an adaptation of Chinese acupuncture. Instead of relying on metaphors to describe the body’s responses to treatment, they employ current knowledge of anatomy and pathology, keeping with evidence-based medicine.

Intended Audience:

• Tendinitis medicines manufacturers


• Tendinitis medicines and treatment providers


• Medical Research laboratories


• Research and Development (R&D) Companies


• Market Research and Consulting Service Providers


• Potential Investors